Copyright Reports & Markets. All rights reserved.

Global Lung Cancer Liquid Biops Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Exosomes and RNA
    • 1.4.3 CTCs and ctDNA
  • 1.5 Market by Application
    • 1.5.1 Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals and Clinics
    • 1.5.3 Physicians'office Laboratories
    • 1.5.4 Clinical Diagnostic Laboratories
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Lung Cancer Liquid Biops Market Perspective (2015-2026)
  • 2.2 Global Lung Cancer Liquid Biops Growth Trends by Regions
    • 2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Lung Cancer Liquid Biops Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Lung Cancer Liquid Biops Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Lung Cancer Liquid Biops Players by Market Size
    • 3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2015-2020)
    • 3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Lung Cancer Liquid Biops Market Concentration Ratio
    • 3.2.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2019
  • 3.3 Lung Cancer Liquid Biops Key Players Head office and Area Served
  • 3.4 Key Players Lung Cancer Liquid Biops Product Solution and Service
  • 3.5 Date of Enter into Lung Cancer Liquid Biops Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2015-2020)
  • 4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Lung Cancer Liquid Biops Market Size by Application (2015-2020)
  • 5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lung Cancer Liquid Biops Market Size (2015-2020)
  • 6.2 Lung Cancer Liquid Biops Key Players in North America (2019-2020)
  • 6.3 North America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 6.4 North America Lung Cancer Liquid Biops Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Lung Cancer Liquid Biops Market Size (2015-2020)
  • 7.2 Lung Cancer Liquid Biops Key Players in Europe (2019-2020)
  • 7.3 Europe Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 7.4 Europe Lung Cancer Liquid Biops Market Size by Application (2015-2020)

8 China

  • 8.1 China Lung Cancer Liquid Biops Market Size (2015-2020)
  • 8.2 Lung Cancer Liquid Biops Key Players in China (2019-2020)
  • 8.3 China Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 8.4 China Lung Cancer Liquid Biops Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Lung Cancer Liquid Biops Market Size (2015-2020)
  • 9.2 Lung Cancer Liquid Biops Key Players in Japan (2019-2020)
  • 9.3 Japan Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 9.4 Japan Lung Cancer Liquid Biops Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Lung Cancer Liquid Biops Market Size (2015-2020)
  • 10.2 Lung Cancer Liquid Biops Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Lung Cancer Liquid Biops Market Size by Application (2015-2020)

11 India

  • 11.1 India Lung Cancer Liquid Biops Market Size (2015-2020)
  • 11.2 Lung Cancer Liquid Biops Key Players in India (2019-2020)
  • 11.3 India Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 11.4 India Lung Cancer Liquid Biops Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Lung Cancer Liquid Biops Market Size (2015-2020)
  • 12.2 Lung Cancer Liquid Biops Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Lung Cancer Liquid Biops Market Size by Type (2015-2020)
  • 12.4 Central & South America Lung Cancer Liquid Biops Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Biocept
    • 13.1.1 Biocept Company Details
    • 13.1.2 Biocept Business Overview
    • 13.1.3 Biocept Lung Cancer Liquid Biops Introduction
    • 13.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2015-2020))
    • 13.1.5 Biocept Recent Development
  • 13.2 EntroGen
    • 13.2.1 EntroGen Company Details
    • 13.2.2 EntroGen Business Overview
    • 13.2.3 EntroGen Lung Cancer Liquid Biops Introduction
    • 13.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.2.5 EntroGen Recent Development
  • 13.3 Cynvenio Biosystems
    • 13.3.1 Cynvenio Biosystems Company Details
    • 13.3.2 Cynvenio Biosystems Business Overview
    • 13.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
    • 13.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.3.5 Cynvenio Biosystems Recent Development
  • 13.4 Exosome Diagnostics
    • 13.4.1 Exosome Diagnostics Company Details
    • 13.4.2 Exosome Diagnostics Business Overview
    • 13.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
    • 13.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.4.5 Exosome Diagnostics Recent Development
  • 13.5 F. Hoffmann-La Roche
    • 13.5.1 F. Hoffmann-La Roche Company Details
    • 13.5.2 F. Hoffmann-La Roche Business Overview
    • 13.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
    • 13.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.5.5 F. Hoffmann-La Roche Recent Development
  • 13.6 Clearbridge BioMedics
    • 13.6.1 Clearbridge BioMedics Company Details
    • 13.6.2 Clearbridge BioMedics Business Overview
    • 13.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
    • 13.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.6.5 Clearbridge BioMedics Recent Development
  • 13.7 Bio-Rad Laboratories
    • 13.7.1 Bio-Rad Laboratories Company Details
    • 13.7.2 Bio-Rad Laboratories Business Overview
    • 13.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
    • 13.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.7.5 Bio-Rad Laboratories Recent Development
  • 13.8 Agena Bioscience
    • 13.8.1 Agena Bioscience Company Details
    • 13.8.2 Agena Bioscience Business Overview
    • 13.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
    • 13.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.8.5 Agena Bioscience Recent Development
  • 13.9 Cancer Genetics
    • 13.9.1 Cancer Genetics Company Details
    • 13.9.2 Cancer Genetics Business Overview
    • 13.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
    • 13.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.9.5 Cancer Genetics Recent Development
  • 13.10 CellMax Life
    • 13.10.1 CellMax Life Company Details
    • 13.10.2 CellMax Life Business Overview
    • 13.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
    • 13.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 13.10.5 CellMax Life Recent Development
  • 13.11 Nateras
    • 10.11.1 Nateras Company Details
    • 10.11.2 Nateras Business Overview
    • 10.11.3 Nateras Lung Cancer Liquid Biops Introduction
    • 10.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.11.5 Nateras Recent Development
  • 13.12 MedGenome
    • 10.12.1 MedGenome Company Details
    • 10.12.2 MedGenome Business Overview
    • 10.12.3 MedGenome Lung Cancer Liquid Biops Introduction
    • 10.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.12.5 MedGenome Recent Development
  • 13.13 OncoDNA
    • 10.13.1 OncoDNA Company Details
    • 10.13.2 OncoDNA Business Overview
    • 10.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
    • 10.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.13.5 OncoDNA Recent Development
  • 13.14 Genomic Health
    • 10.14.1 Genomic Health Company Details
    • 10.14.2 Genomic Health Business Overview
    • 10.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
    • 10.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.14.5 Genomic Health Recent Development
  • 13.15 Trovagene
    • 10.15.1 Trovagene Company Details
    • 10.15.2 Trovagene Business Overview
    • 10.15.3 Trovagene Lung Cancer Liquid Biops Introduction
    • 10.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.15.5 Trovagene Recent Development
  • 13.16 Fluxion Biosciences
    • 10.16.1 Fluxion Biosciences Company Details
    • 10.16.2 Fluxion Biosciences Business Overview
    • 10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
    • 10.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.16.5 Fluxion Biosciences Recent Development
  • 13.17 Biodesix
    • 10.17.1 Biodesix Company Details
    • 10.17.2 Biodesix Business Overview
    • 10.17.3 Biodesix Lung Cancer Liquid Biops Introduction
    • 10.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.17.5 Biodesix Recent Development
  • 13.18 Epic Sciences
    • 10.18.1 Epic Sciences Company Details
    • 10.18.2 Epic Sciences Business Overview
    • 10.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
    • 10.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.18.5 Epic Sciences Recent Development
  • 13.19 Shuwen Biotech
    • 10.19.1 Shuwen Biotech Company Details
    • 10.19.2 Shuwen Biotech Business Overview
    • 10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
    • 10.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.19.5 Shuwen Biotech Recent Development
  • 13.20 Personal Genome Diagnostics
    • 10.20.1 Personal Genome Diagnostics Company Details
    • 10.20.2 Personal Genome Diagnostics Business Overview
    • 10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
    • 10.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.20.5 Personal Genome Diagnostics Recent Development
  • 13.21 Predicine
    • 10.21.1 Predicine Company Details
    • 10.21.2 Predicine Business Overview
    • 10.21.3 Predicine Lung Cancer Liquid Biops Introduction
    • 10.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2015-2020)
    • 10.21.5 Predicine Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Lung Cancer Liquid Biops market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Biocept
    EntroGen
    Cynvenio Biosystems
    Exosome Diagnostics
    F. Hoffmann-La Roche
    Clearbridge BioMedics
    Bio-Rad Laboratories
    Agena Bioscience
    Cancer Genetics
    CellMax Life
    Nateras
    MedGenome
    OncoDNA
    Genomic Health
    Trovagene
    Fluxion Biosciences
    Biodesix
    Epic Sciences
    Shuwen Biotech
    Personal Genome Diagnostics
    Predicine

    Market segment by Type, the product can be split into
    Exosomes and RNA
    CTCs and ctDNA
    Market segment by Application, split into
    Hospitals and Clinics
    Physicians'office Laboratories
    Clinical Diagnostic Laboratories

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now